Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 34
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Sci Rep ; 11(1): 19276, 2021 09 29.
Artículo en Inglés | MEDLINE | ID: mdl-34588573

RESUMEN

Multidrug-resistant (MDR) Salmonella is a threat to public health. Non-antibiotic therapies could serve as important countermeasures to control MDR Salmonella outbreaks. In this study, antimicrobial activity of cationic α-helical bovine NK-lysin-derived antimicrobial peptides was evaluated against MDR Salmonella outbreak isolates. NK2A and NK2B strongly inhibited MDR Salmonella growth while NK1 and NK2C showed minimum-to-no growth inhibition. Scrambled-NK2A, which is devoid of α-helicity but has the same net positive charge as NK2A, also failed to inhibit bacterial growth. Incubation of negatively charged MDR Salmonella with NK2A showed increased Zeta potential, indicating bacterial-peptide electrostatic attraction. Confocal and transmission electron microscopy studies revealed NK2A-mediated damage to MDR Salmonella membranes. LPS inhibited NK2A-mediated growth suppression in a dose-dependent response, suggesting irreversible NK2A-LPS binding. LPS-NK2A binding and bacterial membrane disruption was also confirmed via electron microscopy using gold nanoparticle-NK2A conjugates. Finally, NK2A-loaded polyanhydride nanoparticles showed sustained peptide delivery and anti-bacterial activity. Together, these findings indicate that NK2A α-helicity and positive charge are prerequisites for antimicrobial activity and that MDR Salmonella killing is mediated by direct interaction of NK2A with LPS and the inner membrane, leading to bacterial membrane permeabilization. With further optimization using nano-carriers, NK2A has the potential to become a potent anti-MDR Salmonella agent.


Asunto(s)
Péptidos Antimicrobianos/farmacología , Proteolípidos/farmacología , Infecciones por Salmonella/tratamiento farmacológico , Salmonella/efectos de los fármacos , Animales , Péptidos Antimicrobianos/síntesis química , Péptidos Antimicrobianos/uso terapéutico , Bovinos , Modelos Animales de Enfermedad , Brotes de Enfermedades/prevención & control , Evaluación Preclínica de Medicamentos , Farmacorresistencia Bacteriana Múltiple , Femenino , Humanos , Inyecciones Intraperitoneales , Ratones , Pruebas de Sensibilidad Microbiana , Proteolípidos/síntesis química , Proteolípidos/uso terapéutico , Infecciones por Salmonella/microbiología
2.
Antiviral Res ; 192: 105104, 2021 08.
Artículo en Inglés | MEDLINE | ID: mdl-34087253

RESUMEN

Antimicrobial peptides (AMP) comprise a wide range of small molecules with direct antibacterial activity and immunostimulatory role and are proposed as promising substitutes of the antibiotics. Additionally, they also exert a role against other pathogens such as viruses and fungi less evaluated. NK-lysin, a human granulysin orthologue, possess a double function, taking part in the innate immunity as AMP and also as direct effector in the cell-mediated cytotoxic (CMC) response. This molecule is suggested as a pivotal molecule involved in the defence upon nervous necrosis virus (NNV), an epizootic virus provoking serious problems in welfare and health status in Asian and Mediterranean fish destined to human consumption. Having proved that NK-lysin derived peptides (NKLPs) have a direct antiviral activity against NNV in vitro, we aimed to evaluate their potential use as a prophylactic treatment for European sea bass (Dicentrarchus labrax), one of the most susceptible cultured-fish species. Thus, intramuscular injection of synthetic NKLPs resulted in a very low transcriptional response of some innate and adaptive immune markers. However, the injection of NKLPs ameliorated disease signs and increased fish survival upon challenge with pathogenic NNV. Although NKLPs showed promising results in treatments against NNV, more efforts are needed to understand their mechanisms of action and their applicability to the aquaculture industry.


Asunto(s)
Lubina/virología , Encefalopatías/veterinaria , Enfermedades de los Peces/prevención & control , Nodaviridae/efectos de los fármacos , Péptidos/uso terapéutico , Proteolípidos/uso terapéutico , Enfermedades de la Retina/veterinaria , Animales , Antivirales/administración & dosificación , Antivirales/síntesis química , Acuicultura , Encefalopatías/mortalidad , Encefalopatías/prevención & control , Encefalopatías/virología , Resistencia a la Enfermedad/efectos de los fármacos , Enfermedades de los Peces/mortalidad , Enfermedades de los Peces/virología , Inyecciones Intramusculares , Nodaviridae/patogenicidad , Péptidos/administración & dosificación , Péptidos/síntesis química , Proteolípidos/administración & dosificación , Proteolípidos/síntesis química , Infecciones por Virus ARN/mortalidad , Infecciones por Virus ARN/prevención & control , Infecciones por Virus ARN/veterinaria , Infecciones por Virus ARN/virología , Enfermedades de la Retina/mortalidad , Enfermedades de la Retina/prevención & control , Enfermedades de la Retina/virología , Tasa de Supervivencia
3.
Angew Chem Int Ed Engl ; 59(13): 5178-5184, 2020 03 23.
Artículo en Inglés | MEDLINE | ID: mdl-31846559

RESUMEN

The preparation of native S-palmitoylated (S-palm) membrane proteins is one of the unsolved challenges in chemical protein synthesis. Herein, we report the first chemical synthesis of S-palm membrane proteins by removable-backbone-modification-assisted Ser/Thr ligation (RBMGABA -assisted STL). This method involves two critical steps: 1) synthesis of S-palm peptides by a new γ-aminobutyric acid based RBM (RBMGABA ) strategy, and 2) ligation of the S-palm RBM-modified peptides to give the desired S-palm product by the STL method. The utility of the RBMGABA -assisted STL method was demonstrated by the synthesis of rabbit S-palm sarcolipin (SLN) and S-palm matrix-2 (M2) ion channel. The synthesis of S-palm membrane proteins highlights the importance of developing non-NCL methods for chemical protein synthesis.


Asunto(s)
Proteínas de la Membrana/química , Palmitatos/química , Péptidos/síntesis química , Serina/química , Treonina/química , Secuencia de Aminoácidos , Aminobutiratos/química , Animales , Canales Iónicos/síntesis química , Proteínas Musculares/síntesis química , Proteolípidos/síntesis química , Conejos , Técnicas de Síntesis en Fase Sólida , Solubilidad
4.
Acta Biomater ; 76: 1-20, 2018 08.
Artículo en Inglés | MEDLINE | ID: mdl-29625253

RESUMEN

Cell-free (CF) protein synthesis has emerged as a powerful technique platform for efficient protein production in vitro. Liposomes have been widely studied as therapeutic carriers due to their biocompatibility, biodegradability, low toxicity, flexible surface manipulation, easy preparation, and higher cargo encapsulation capability. However, rapid immune clearance, insufficient targeting capacity, and poor cytoplasmic delivery efficiency substantially restrict their clinical application. The incorporation of functional membrane proteins (MPs) or peptides allows the transfer of biological properties to liposomes and imparts them with improved circulation, increased targeting, and efficient intracellular delivery. Liposome-chaperoned CF synthesis enables production of proteoliposomes in one-step reaction, which not only substantially simplifies the production procedure but also keeps protein functionality intact. Building off these observations, proteoliposomes with integrated MPs represent an excellent candidate for therapeutic delivery. In this review, we describe recent advances in CF synthesis with emphasis on detailing key factors for improving CF expression efficiency. Furthermore, we provide insights into strategies for rational design of proteoliposomal nanodelivery systems via CF synthesis. STATEMENT OF SIGNIFICANCE: Liposome-chaperoned CF synthesis has emerged as a powerful approach for the design of recombinant proteoliposomes in one-step reaction. The incorporation of bioactive MPs or peptides into liposomes via CF synthesis can facilitate the development of proteoliposomal nanodelivery systems with improved circulation, increased targeting, and enhanced cellular delivery capacity. Moreover, by adapting lessons learned from natural delivery vehicles, novel bio-inspired proteoliposomes with enhanced delivery properties could be produced in CF systems. In this review, we first give an overview of CF synthesis with focus on enhancing protein expression in liposome-chaperoned CF systems. Furthermore, we intend to provide insight into harnessing CF-synthesized proteoliposomes for efficient therapeutic delivery.


Asunto(s)
Sistemas de Liberación de Medicamentos/métodos , Chaperonas Moleculares/química , Biosíntesis de Proteínas , Proteolípidos/química , Proteolípidos/síntesis química , Sistema Libre de Células/química
5.
Bioengineered ; 9(1): 6-11, 2018 Jan 01.
Artículo en Inglés | MEDLINE | ID: mdl-28463573

RESUMEN

The need for cost-effectively produced and improved biocatalysts for industrial, pharmaceutical and environmental processes is steadily increasing. While enzyme properties themselves can be improved via protein engineering, immobilization by attachment to carrier materials remains a critical step for stabilization and process implementation. A new emerging immobilization approach, the in situ immobilization, enables simultaneous production of highly active enzymes and carrier materials using bioengineering/synthetic biology of microbial cells. In situ enzyme immobilization holds the promise of cost-effective production of highly functional immobilized biocatalysts for uses such as in bioremediation, drug synthesis, bioenergy and food processing.


Asunto(s)
Enzimas Inmovilizadas/química , Cuerpos de Inclusión/enzimología , Magnetosomas/enzimología , Polihidroxialcanoatos/química , Ingeniería de Proteínas/métodos , Adsorción , Biocatálisis , Biodegradación Ambiental , Reactivos de Enlaces Cruzados/química , Enzimas Inmovilizadas/genética , Enzimas Inmovilizadas/metabolismo , Manipulación de Alimentos/métodos , Expresión Génica , Cuerpos de Inclusión/genética , Magnetosomas/genética , Proteolípidos/síntesis química , Proteolípidos/metabolismo , Proteínas Recombinantes de Fusión/biosíntesis , Proteínas Recombinantes de Fusión/genética , Proteínas Recombinantes de Fusión/metabolismo
6.
J Comput Aided Mol Des ; 31(9): 841-854, 2017 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-28756481

RESUMEN

Proteolipid protein (PLP) is one of the main proteins of myelin sheath that are destroyed during the progress of multiple sclerosis (MS). The immunodominant PLP139-151 epitope is known to induce experimental autoimmune encephalomyelitis (EAE, animal model of MS), wherein residues 144 and 147 are recognized by T cell receptor (TCR) during the formation of trimolecular complex with peptide-antigen and major histocompability complex. The conformational behavior of linear and cyclic peptide analogues of PLP, namely PLP139-151 and cyclic (139-151) (L144, R147) PLP139-151, have been studied in solution by means of nuclear magnetic resonance (NMR) methods in combination with unrestrained molecular dynamics simulations. The results indicate that the side chains of mutated amino acids in the cyclic analogue have different spatial orientation compared with the corresponding side chains of the linear analogue, which can lead to reduced affinity to TCR. NMR experiments combined with theoretical calculations pave the way for the design and synthesis of potent restricted peptides of immunodominant PLP139-151 epitope as well as non peptide mimetics that rises as an ultimate goal.


Asunto(s)
Simulación de Dinámica Molecular , Fragmentos de Péptidos/química , Péptidos Cíclicos/química , Proteolípidos/química , Diseño de Fármacos , Humanos , Espectroscopía de Resonancia Magnética , Conformación Molecular , Fragmentos de Péptidos/síntesis química , Fragmentos de Péptidos/genética , Péptidos Cíclicos/síntesis química , Péptidos Cíclicos/genética , Proteolípidos/síntesis química , Proteolípidos/genética , Relación Estructura-Actividad Cuantitativa
7.
Chembiochem ; 14(17): 2243-7, 2013 Nov 25.
Artículo en Inglés | MEDLINE | ID: mdl-24115581

RESUMEN

Heat, we leak: We express a membrane protein outside well-defined giant liposomes obtained by gravity-transferred sucrose-in-oil droplets into a cell-free, reconstituted expression system. We show that the presence of the liposome is necessary during expression for efficient protein insertion into the membrane and that temperature can trigger the resulting membrane function.


Asunto(s)
Liposomas/síntesis química , Liposomas/metabolismo , Proteínas de la Membrana/metabolismo , Proteolípidos/metabolismo , Sistema Libre de Células , Liposomas/química , Tamaño de la Partícula , Proteolípidos/síntesis química , Proteolípidos/química , Sacarosa , Propiedades de Superficie , Temperatura , Factores de Tiempo
8.
Artif Cells Nanomed Biotechnol ; 41(5): 309-14, 2013 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-23305602

RESUMEN

OBJECTIVE: The objective of the present study was to develop targeted engineered nanoerythrosomes based intravenous formulation of antimalarial drug pyrimethamine. MATERIAL AND METHODS: The nanoerythrosomes formulation was developed by sonication method and optimized for effective drug loading at variable drug concentration, surface morphology, viscosity and sedimentation volume. RESULTS: The in vitro drug release of formulated product was found to be delayed after 8 hours, having good stability at 4 ± 1°C and showing controlled in vivo release. Tissue distribution studies showed higher accumulation of drug in the liver (18.71 ± 1.4 µg/ml) (P < 0.05) at 1 hour in case of pyrimethamine-loaded nanoerythrosomes as compared to that in free drug (12.82 ± 0.7 µg/ml). Higher amount of drug, i.e. 14.18 ± 0.9 µg/ml (P < 0.05), was found after 24 hours in the liver in case of pyrimethamine-loaded nanoerythrosomes as compared to free drug concentration of 9.72 ± 0.5 µg/ml). DISCUSSION: Data showed that developed pyrimethamine-loaded nanoerythrosomes hold promise for targeting and controlling the release of drug and for improving treatment of malaria when they are combined with rapid acting antimalarials such as artemisinin. CONCLUSION: A decrease in the concentration of pyrimethamine in kidneys and lungs after 24 hours was observed as compared to that observed after 1 hour, showing no or little involvement of these organs in the clearance of drug-loaded nanoerythrosomes.


Asunto(s)
Antimaláricos/farmacocinética , Hígado/metabolismo , Nanoestructuras/administración & dosificación , Proteolípidos/administración & dosificación , Pirimetamina/farmacocinética , Implantes Absorbibles/estadística & datos numéricos , Animales , Antimaláricos/química , Bioingeniería/métodos , Sistemas de Liberación de Medicamentos/tendencias , Femenino , Semivida , Humanos , Masculino , Nanoestructuras/química , Proteolípidos/síntesis química , Pirimetamina/química , Ratas , Ratas Endogámicas
9.
Eur Phys J E Soft Matter ; 34(6): 63, 2011 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-21706281

RESUMEN

The size polydispersity distribution of synaptic vesicles (SVs) is characterized under quasi-physiological conditions by dynamic light scattering (DLS). Highly purified fractions of SVs obtained from rat brain still contain a small amount of larger contaminant structures, which can be quantified by DLS and further reduced by asymmetric-flow field-flow (AFFF) fractionation. The intensity autocorrelation functions g (2)(τ) recorded from these samples are analyzed by a constrained regularization method as well as by an alternative direct modeling approach. The results are in quantitative agreement with the polydispersity obtained from cryogenic electron microscopy of vitrified SVs. Next, different vesicle fusion assays based on samples composed of SVs and small unilamellar proteoliposomes with the fusion proteins syntaxin 1 and SNAP-25A are characterized by DLS. The size increase of the proteoliposomes due to SNARE-dependent fusion with SVs is quantified by DLS under quasi-physiological conditions.


Asunto(s)
Microscopía por Crioelectrón/métodos , Proteolípidos/química , Proteínas SNARE/análisis , Proteínas SNARE/química , Vesículas Sinápticas/química , Vesículas Sinápticas/ultraestructura , Difracción de Rayos X/instrumentación , Animales , Encéfalo/citología , Encéfalo/metabolismo , Cromatografía Liquida , Simulación por Computador , Luz , Fusión de Membrana , Proteínas del Tejido Nervioso/análisis , Proteínas del Tejido Nervioso/química , Proteínas del Tejido Nervioso/metabolismo , Proteolípidos/análisis , Proteolípidos/síntesis química , Proteínas R-SNARE/análisis , Proteínas R-SNARE/química , Proteínas R-SNARE/metabolismo , Ratas , Proteínas SNARE/metabolismo , Dispersión de Radiación , Dispersión del Ángulo Pequeño , Vesículas Sinápticas/metabolismo , Proteína 25 Asociada a Sinaptosomas/análisis , Proteína 25 Asociada a Sinaptosomas/química , Proteína 25 Asociada a Sinaptosomas/metabolismo , Sintaxina 1/análisis , Sintaxina 1/química , Sintaxina 1/metabolismo
10.
Bioconjug Chem ; 21(2): 345-51, 2010 Feb 17.
Artículo en Inglés | MEDLINE | ID: mdl-20078100

RESUMEN

To develop a sterically stable, targeting proteoliposome, a postinsertion method was employed to biofunctionalize the liposome surface with a biocompatible anchor molecule (BAM) linker conjugated with epidermal growth factor (EGF) as a homing molecule. In this method, EGF was first conjugated with BAM that consisted of a hydrophilic reactive group at one end and oleic acid chains at the other end. The EGF-BAM complex was then inserted into the liposomal phospholipid bilayer through lipophilic interaction. When compared with the traditional surface modification method by amine coupling, the modification efficiency with BAM at 25 degrees C was about 2.5-fold higher, and the 24 h stability of the inserted BAM at 25 degrees C was also about 2.5-fold higher. The insertion affinity and stability of the BAM to the liposomal bilayer was not influenced by an increase in cholesterol concentration, a component in liposome preparation. Confocal microscopy studies showed that the proteoliposomes biofunctionalized with the BAM-EGF complex encapsulating Cy5 fluorescent dye were selectively bound to the surface of MDA-MB-231 cells overexpressing EGFR (epidermal growth factor receptor), but not to MCF-7 cells, which did not express EGFR. The same proteolipome encapsulating doxorubicin was selectively targeted to MDA-MB-231 cells and killed them. In sum, BAM could be used as a suitable postinsertion linker for biofunctionalization of liposome surface with high modification efficiency and stability. Furthermore, the protein used as a homing molecule maintained its bioactivity after the biofunctionalization.


Asunto(s)
Factor de Crecimiento Epidérmico/química , Proteolípidos/química , Proteínas Recombinantes/química , Materiales Biocompatibles/química , Línea Celular Tumoral , Colesterol/química , Portadores de Fármacos/síntesis química , Portadores de Fármacos/química , Estabilidad de Medicamentos , Factor de Crecimiento Epidérmico/metabolismo , Humanos , Liposomas/química , Fosfolípidos/química , Proteolípidos/síntesis química , Proteínas Recombinantes/metabolismo , Temperatura
11.
Langmuir ; 25(23): 13322-7, 2009 Dec 01.
Artículo en Inglés | MEDLINE | ID: mdl-19883092

RESUMEN

In this letter, we present a simple one-step, versatile, scalable chemical vapor deposition (CVD)-based process for the encapsulation and stabilization of a host of single or multicomponent supramolecular assemblies (proteoliposomes, microbubbles, lipid bilayers, and photosynthetic antennae complexes and other biological materials) to form functional hybrid nanobiomaterials. In each case, it is possible (i) to form thin silica layers or gels controllably that enable the preservation of the supramolecular assembly over time and under adverse environmental conditions and (ii) to tune the structure of the silica gels so as to optimize solute accessibility while at the same time preserving functional dynamic properties of the encapsulated phospholipid assembly. The process allows precise temporal and spatial control of silica polymerization kinetics through the control of precursor delivery at room temperature and does not require or produce high concentrations of injurious chemicals that can compromise the function of biomolecular assemblies; it also does not require additives. This process differs from the conventional sol-gel process in that it does not involve the use of cosolvents (alcohols) and catalysts (acid or base).


Asunto(s)
Materiales Biocompatibles/síntesis química , Nanoestructuras/química , Nanotecnología/métodos , Materiales Biocompatibles/química , Electroquímica , Geles/química , Cinética , Membrana Dobles de Lípidos/síntesis química , Membrana Dobles de Lípidos/química , Microscopía Electrónica de Rastreo , Nanoestructuras/ultraestructura , Proteolípidos/síntesis química , Proteolípidos/química , Dióxido de Silicio/química
12.
Curr Protoc Protein Sci ; Chapter 5: 5.22.1-5.22.30, 2008 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-19016436

RESUMEN

Limitations in the production of folded membrane proteins represent the major bottleneck for functional and structural studies of this huge category of macromolecules. Cell-free expression systems provide an attractive alternative to the classical overexpression systems for producing membrane proteins. However, optimization of these systems remains a challenging task, considering the hydrophobic properties of these molecules. This unit describes the production of eukaryotic membrane proteins either in soluble form or integrated into liposomes using a bacterial cell-free expression system. Liposomes in the reaction mixture induce the direct insertion of freshly produced membrane proteins into the bilayer and allow the formation of functional proteoliposomes in which the membrane proteins are correctly folded.


Asunto(s)
ADN Complementario/metabolismo , Expresión Génica , Proteínas de la Membrana/biosíntesis , Proteínas de la Membrana/metabolismo , Proteolípidos/síntesis química , Proteolípidos/metabolismo , Animales , Clonación Molecular , Electroforesis , Escherichia coli/genética , Escherichia coli/metabolismo , Humanos , Immunoblotting , Proteínas de la Membrana/química , Pliegue de Proteína , Proteolípidos/química , Proteínas Recombinantes/biosíntesis
13.
Ultramicroscopy ; 91(1-4): 245-51, 2002 May.
Artículo en Inglés | MEDLINE | ID: mdl-12211475

RESUMEN

The submicron domain structure of coexisting liquid condensed (LC) and liquid expanded (LE) phases in monolayers composed of palmitic acid and 20 wt% of a lung surfactant protein B fragment has been investigated. Near-field microscopy was used to simultaneously measure topography and fluorescence images of monolayers that were prepared at a surface pressure of 15 mN/m and a temperature of 22 degrees C. The use of a fluorescently tagged peptide allowed for unambiguous determination of the peptide location in the two-component system. The LC and LE phases in the monolayers are measured on the submicron length scale. A 6-11 A height difference between the LC and LE phases was evident in the height images. Gradual transitions between the LC and LE domains were observed across a 1.3 microm length scale in the near-field fluorescence images, but were significantly sharper in the simultaneously collected topography images and in the separately measured AFM images. These results may reflect the occurrence of peptide encroachment into the LC domains.


Asunto(s)
Microscopía/métodos , Proteolípidos/química , Proteolípidos/ultraestructura , Surfactantes Pulmonares/química , Surfactantes Pulmonares/ultraestructura , Humanos , Recién Nacido , Microscopía/instrumentación , Ácido Palmítico/síntesis química , Ácido Palmítico/química , Proteolípidos/síntesis química , Surfactantes Pulmonares/síntesis química , Síndrome de Dificultad Respiratoria del Recién Nacido/fisiopatología
14.
J Membr Biol ; 187(3): 185-201, 2002 Jun 01.
Artículo en Inglés | MEDLINE | ID: mdl-12163977

RESUMEN

Recently, we reported indirect evidence that plasma membrane Ca2+-ATPase (PMCA) can mediate B-type Ca2+ channels of cardiac myocytes. In the present study, in order to bring more direct evidence, purified PMCA from human red blood cells (RBC) was reconstituted into giant azolectin liposomes amenable to the patch-clamp technique. Purified RBC PMCA was used because it is available pure in larger quantity than cardiac PMCA. The presence of B-type Ca2+ channels was first investigated in native membranes of human RBC. They were detected and share the characteristics of cardiac myocytes. They spontaneously appeared in scarce short bursts of activity, they were activated by chlorpromazine (CPZ) with an EC50 of 149 mmole/l or 1 mmole/l vanadate, and then switched off by 10 mmole/l eosin or dose-dependently blocked by 1-5 mmole/l ATP. Independent of membrane potential, the channel gating exhibited complex patterns of many conductance levels, with three most often observed conductance levels of 22, 47 and 80 pS. The activation by vanadate suggests that these channels could play a role in the influx of extracellular Ca2+ involved in the vanadate-induced Gardos effect. In PMCA-reconstituted proteoliposomes, nearly half of the ATPase activity was retained and clear "channel-like" openings of Ba2+- or Ca2+-conducting channels were detected. Channel activity could be spontaneously present, lasting the patch lifetime or, when previously quiescent, activity could be induced by application of 50 mmole/l CPZ only in presence of 25 U/ml calmodulin (CaM), or by application of 1 mmole/l vanadate alone. Eosin (10 mmole/l) and ATP (5 mmole/l) significantly reduced spontaneous activity. Channel gating characteristics were similar to those of RBC, with main conductance levels of 21, 40 and 72 pS. The lack of direct activation by CPZ alone might be attributed to a purification-induced modification or absence of unidentified regulatory component(s) of PMCA. Despite a few differences in results between RBC and reincorporated PMCA, most probably attributable to the decrease in ATPase activity following the procedure of reincorporation, the present experimental conditions appear to reveal a channel-mode of the PMCA that shares many similarities with the B-type Ca2+ channel.


Asunto(s)
Canales de Calcio/fisiología , ATPasas Transportadoras de Calcio/metabolismo , Eritrocitos/metabolismo , Proteolípidos/fisiología , Adenosina Trifosfato/farmacología , Canales de Calcio/efectos de los fármacos , ATPasas Transportadoras de Calcio/aislamiento & purificación , Calmodulina/farmacología , Proteínas de Transporte de Catión , Membrana Celular/fisiología , Clorpromazina/farmacología , Relación Dosis-Respuesta a Droga , Conductividad Eléctrica , Eosina Amarillenta-(YS)/farmacología , Humanos , Potenciales de la Membrana/efectos de los fármacos , Potenciales de la Membrana/fisiología , Técnicas de Placa-Clamp , ATPasas Transportadoras de Calcio de la Membrana Plasmática , Proteolípidos/síntesis química , Proteolípidos/efectos de los fármacos , Vanadatos/farmacología
15.
Toxicology ; 159(3): 119-33, 2001 Feb 28.
Artículo en Inglés | MEDLINE | ID: mdl-11223168

RESUMEN

The reduction of chromium(VI) to Cr(III) results in the formation of reactive intermediates that contribute to the cytotoxicity, genotoxicity, and carcinogenicity of Cr(VI)-containing compounds. Previous studies suggest that human microsomal Cr(VI) reduction likely proceeds through cytochrome b(5). In order to better understand Cr(VI) toxicity in humans, the role of cytochrome b(5) in combination with P450 reductase was examined in the reductive transformation of Cr(VI). Proteoliposomes containing human recombinant cytochrome b(5) and P450 reductase were constructed. The ability of P450 reductase to mediate efficient electron transfer from NADPH to cytochrome b(5) was confirmed by spectral analysis. The NADPH-dependent Cr(VI) reduction rate mediated by proteoliposomes was then compared to that of human microsomes. When these rates were normalized to equivalent cytochrome b(5) concentrations, the NADPH-dependent Cr(VI) reduction rates mediated by human microsomes were essentially identical to those for proteoliposomes containing cytochrome b(5) plus P450 reductase. Proteoliposomes containing only P450 reductase or cytochrome b(5) exhibited poor Cr(VI) reducing capabilities. Since it had been previously shown that trace amounts of iron (Fe) could dramatically stimulate microsomal Cr(VI) reduction, the ability of Fe to stimulate Cr(VI) reduction by proteoliposomes was examined. Both ferric chloride (FeCl(3)) and ferric adenosine-5'-diphosphate (FeADP) were shown to stimulate Cr(VI) reduction; this stimulation could be abolished by the addition of deferoxamine, a specific Fe(III) chelator. The NADPH-dependent reduction rates of various ferric complexes by proteoliposomes were sufficient to account for the increased Cr(VI) reduction rates seen with the addition of FeCl(3) or FeADP. Cr(V) was detected by electron paramagnetic resonance (EPR) spectroscopy as a transient intermediate formed during NADPH-dependent Cr(VI) reduction mediated by proteoliposomes containing cytochrome b(5) and P450 reductase. Overall, cytochrome b(5) in combination with P450 reductase can account for the majority of the NADPH-dependent Cr(VI) reduction seen with human microsomes.


Asunto(s)
Adenosina Difosfato/análogos & derivados , Cromo/metabolismo , Citocromos b5/metabolismo , Microsomas Hepáticos/enzimología , Adenosina Difosfato/farmacología , Cloruros , Deferoxamina/farmacología , Compuestos Férricos/farmacología , Humanos , Liposomas/síntesis química , Liposomas/metabolismo , NADPH-Ferrihemoproteína Reductasa/metabolismo , Oxidación-Reducción , Proteolípidos/síntesis química , Proteolípidos/metabolismo , Proteínas Recombinantes
16.
Biol Pharm Bull ; 24(12): 1362-5, 2001 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-11767102

RESUMEN

We previously reported that a human analogue of pulmonary surfactant protein-C (SP-C), SP-CL16 (6-28), with 23 residues (Fig. 1) was the most active analogue in a reconstituted lipid mixture and had the shortest chain among the poly-leucine-analogues examined. In the present study, we examined a new method of preparing this analogue, that is, stepwise solid-phase synthesis employing the Fmoc method followed by centrifugal partition chromatography (CPC) using an n-hexane/CH3OH/H2O/trifluoroacetic acid (TFA) (1000: 1000:1:2, v/v) solvent system according to the descending method. The synthetic peptides were identified by matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometry in search of activity to improve the in vitro surface activity of a ternary lipid mixture composed of dipalmitoylphosphatidylcholine, egg-phosphatidylglycerol and palmitic acid (75:25:10, w/w) in a Langmuir-Wilhelmy surface balance. SP-CL16 (6-28) seemed comparable in surface activity with Surfacten (Surfactant-TA), a modified surfactant preparation which has been used for the treatment of respiratory distress syndrome.


Asunto(s)
Proteolípidos/síntesis química , Proteolípidos/aislamiento & purificación , Surfactantes Pulmonares/síntesis química , Surfactantes Pulmonares/aislamiento & purificación , Tensoactivos/síntesis química , Tensoactivos/aislamiento & purificación , Secuencia de Aminoácidos , Humanos , Datos de Secuencia Molecular , Proteolípidos/química , Surfactantes Pulmonares/química , Propiedades de Superficie , Tensoactivos/química
17.
Biochim Biophys Acta ; 1466(1-2): 179-86, 2000 Jun 01.
Artículo en Inglés | MEDLINE | ID: mdl-10825441

RESUMEN

Surfactant proteins B and C (SP-B and SP-C), together with phospholipids, are important constituents of pulmonary surfactant and of preparations used for treatment of respiratory distress syndrome (RDS). SP-B belongs to the saposin family of homologous proteins, which include other lipid-interacting proteins, like the membranolytic NK-lysin. SP-B, in contrast to other saposins, is hydrophobic and a disulfide-linked dimer, and its mechanism of action is not known. A model of the three-dimensional structure of one SP-B subunit was generated from the structure of monomeric NK-lysin determined by nuclear magnetic resonance, and the SP-B dimer was formed by joining two subunits via the intersubunit disulfide bond Cys48-Cys48'. After energy minimization, intersubunit hydrogen bonds/ion pairs were formed between the strictly conserved residues Glu51 and Arg52, which creates a central non-polar region located in between two clusters of positively charged residues. The structural features support a function of SP-B in cross-linking of lipid membranes. Mixtures of phospholipids, an SP-C analogue and polymyxin B (which cross-links lipid vesicles but is structurally unrelated to SP-B) exhibit in vitro surface activity which is indistinguishable from that of analogous mixtures containing SP-B instead of polymyxin B. This suggests an avenue for identification of SP-B analogues that can be used in synthetic surfactants for treatment of RDS.


Asunto(s)
Proteolípidos/química , Surfactantes Pulmonares/química , Secuencia de Aminoácidos , Animales , Reactivos de Enlaces Cruzados , Perros , Humanos , Membrana Dobles de Lípidos/metabolismo , Ratones , Modelos Moleculares , Datos de Secuencia Molecular , Péptidos , Polimixina B , Proteolípidos/síntesis química , Proteolípidos/metabolismo , Proteolípidos/fisiología , Surfactantes Pulmonares/síntesis química , Surfactantes Pulmonares/metabolismo , Surfactantes Pulmonares/fisiología , Conejos , Ratas , Relación Estructura-Actividad , Porcinos
18.
Biochem J ; 343 Pt 3: 557-62, 1999 Nov 01.
Artículo en Inglés | MEDLINE | ID: mdl-10527933

RESUMEN

A method for O- and S-palmitoylation of non-protected peptides has been developed. The peptides are treated with excess of palmitoyl chloride in 100% trifluoroacetic acid for 10 min at room temperature. The acidic conditions prevent acylation of amino groups, which is only significant after prolonged treatment (hours to days). The tripeptides Gly-Cys-Phe and Gly-Ser-Phe were converted into the respective S- and O-palmitoylated compounds, and the hydrophobic pulmonary surfactant protein-C model peptides, LRIPCCPVNLKRLLVVV [SP-C(1-17)] and FGIPSSPVLKRLLILLLLLLLILLLILGALLMGL [SP-C(Leu)] were converted into their respective S,S- and O,O-dipalmitoylated peptides. The reactions were virtually quantitative, and the palmitoylated peptides were isolated in about 75-80% yield after reversed-phase HPLC purification. CD spectroscopy showed that S, S-dipalmitoylation of SP-C(1-17) affects the peptide secondary structure (substantial increase in the alpha-helix content) in dodecylphosphocholine micelles.


Asunto(s)
Glicopéptidos/síntesis química , Oligopéptidos/síntesis química , Ácido Palmítico/química , Procesamiento Proteico-Postraduccional , Proteolípidos/síntesis química , Surfactantes Pulmonares/síntesis química , Secuencia de Aminoácidos , Cromatografía Líquida de Alta Presión , Dicroismo Circular , Glicopéptidos/química , Indicadores y Reactivos , Datos de Secuencia Molecular , Oligopéptidos/química , Ácido Palmítico/metabolismo , Fragmentos de Péptidos/síntesis química , Fragmentos de Péptidos/química , Conformación Proteica , Proteolípidos/química , Proteolípidos/metabolismo , Surfactantes Pulmonares/química , Surfactantes Pulmonares/metabolismo
19.
J Pept Sci ; 4(5): 355-63, 1998 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-9753395

RESUMEN

An efficient synthesis for human-identical lung surfactant protein SP-C is described with a semi-automated solid phase synthesizer using Fmoc chemistry. Double coupling and acetic anhydride capping procedures were employed for synthetic cycles within the highly hydrophobic C-terminal domain of SP-C. Isolation of the protein was performed by mild cleavage and deprotection conditions and subsequent HPLC purification yielding a highly homogeneous protein as established by sequence determination, electrospray, plasma desorption and MALDI mass spectrometry. A general method has been employed for the preparation of Cys-palmitoylated protein by using temporary Cys(tButhio) protection, in situ deprotection with beta-mercaptoethanol and selective palmitoylation of resin-bound SP-C. The mild synthesis and isolation conditions provide SP-C with a high alpha-helical content, comparable to that of the natural SP-C, as assessed by CD spectra. Furthermore, first biophysical data indicate a surfactant activity comparable to that of the natural protein.


Asunto(s)
Proteolípidos/química , Proteolípidos/síntesis química , Surfactantes Pulmonares/química , Surfactantes Pulmonares/síntesis química , Secuencia de Aminoácidos , Cromatografía Líquida de Alta Presión , Dicroismo Circular , Humanos , Datos de Secuencia Molecular
20.
Biol Neonate ; 74 Suppl 1: 9-14, 1998 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-9730586

RESUMEN

Surfactant preparations for the treatment of respiratory distress syndrome (RDS) that contain phospholipids and small amounts of the two hydrophobic proteins, SP-B and SP-C, are presently obtained from animal lungs. Since structural information about SP-B and SP-C is available, it appears possible to design analogues that can replace the native proteins in synthetic surfactants. SP-C contains a single helix, but analogues with the poly-Val sequence of the native molecule do not fold into a native-like alpha-helical conformation. However, replacement of all Val with Leu yields efficient folding into a helical structure and Leu-based SP-C analogues effectively accelerate spreading of surfactant lipids and exhibit some physiological activity in animal models of RDS. The inferior in vivo activity of synthetic surfactants containing SP-C only compared to that of surfactant preparations derived from natural sources may be caused by a lack of covalently linked palmitoyl groups in the analogues and/or absence of SP-B. SP-B is significantly larger than SP-C and has a tertiary fold of several amphipathic helices in a dimeric structure. A single simplified amphipathic helical peptide containing only Leu and Lys does not mimic the surface properties of SP-B in vitro. These circumstances make the design of SP-B analogues from solely structural considerations less likely to be successful than in the case of SP-C.


Asunto(s)
Proteolípidos/síntesis química , Surfactantes Pulmonares/síntesis química , Diseño de Fármacos , Humanos , Recién Nacido , Recien Nacido Prematuro , Proteolípidos/química , Proteolípidos/uso terapéutico , Surfactantes Pulmonares/química , Surfactantes Pulmonares/uso terapéutico , Síndrome de Dificultad Respiratoria del Recién Nacido/tratamiento farmacológico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...